| Product Code: ETC10075216 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Glycopeptide Antibiotics Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Glycopeptide Antibiotics Market - Industry Life Cycle |
3.4 Vietnam Glycopeptide Antibiotics Market - Porter's Five Forces |
3.5 Vietnam Glycopeptide Antibiotics Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Vietnam Glycopeptide Antibiotics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Vietnam Glycopeptide Antibiotics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Vietnam Glycopeptide Antibiotics Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Vietnam Glycopeptide Antibiotics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Vietnam Glycopeptide Antibiotics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases requiring glycopeptide antibiotics treatment |
4.2.2 Growing awareness about the effectiveness of glycopeptide antibiotics in Vietnam |
4.2.3 Favorable government initiatives to promote the use of glycopeptide antibiotics in healthcare settings |
4.3 Market Restraints |
4.3.1 High cost associated with glycopeptide antibiotics leading to limited affordability |
4.3.2 Risk of antibiotic resistance development due to overuse of glycopeptide antibiotics |
4.3.3 Stringent regulations and approval processes for glycopeptide antibiotics in Vietnam |
5 Vietnam Glycopeptide Antibiotics Market Trends |
6 Vietnam Glycopeptide Antibiotics Market, By Types |
6.1 Vietnam Glycopeptide Antibiotics Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Vancomycin, 2021- 2031F |
6.1.4 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Dalbavancin, 2021- 2031F |
6.1.5 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Oritavancin, 2021- 2031F |
6.1.6 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Glycopeptide Antibiotics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Skin and Structure Infection, 2021- 2031F |
6.2.3 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Meningitis, 2021- 2031F |
6.2.4 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Clostridioides Difficile Infection, 2021- 2031F |
6.2.5 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Enterocolitis, 2021- 2031F |
6.2.6 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Vietnam Glycopeptide Antibiotics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Vietnam Glycopeptide Antibiotics Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.5 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Vietnam Glycopeptide Antibiotics Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.5 Vietnam Glycopeptide Antibiotics Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Glycopeptide Antibiotics Market Import-Export Trade Statistics |
7.1 Vietnam Glycopeptide Antibiotics Market Export to Major Countries |
7.2 Vietnam Glycopeptide Antibiotics Market Imports from Major Countries |
8 Vietnam Glycopeptide Antibiotics Market Key Performance Indicators |
8.1 Percentage increase in prescriptions of glycopeptide antibiotics in Vietnam |
8.2 Number of healthcare facilities adopting glycopeptide antibiotics in their treatment protocols |
8.3 Patient satisfaction rates with glycopeptide antibiotic treatments |
8.4 Number of clinical trials and research studies on glycopeptide antibiotics conducted in Vietnam |
8.5 Rate of adverse events or side effects reported with the use of glycopeptide antibiotics in Vietnam |
9 Vietnam Glycopeptide Antibiotics Market - Opportunity Assessment |
9.1 Vietnam Glycopeptide Antibiotics Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Vietnam Glycopeptide Antibiotics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Vietnam Glycopeptide Antibiotics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Vietnam Glycopeptide Antibiotics Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Vietnam Glycopeptide Antibiotics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Vietnam Glycopeptide Antibiotics Market - Competitive Landscape |
10.1 Vietnam Glycopeptide Antibiotics Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Glycopeptide Antibiotics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here